External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home IPIG 2025
Roche and Genentech at

IPIG 2025

May 15 - May 16
Paris, France
ipig2025.com
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
05:30 AM
Duration 60mins Paris, France
Analysis of outcomes after rescue doses in patients with paroxysmal nocturnal hemoglobinuria treated with crovalimab▼ in the Phase 3 COMMODORE 1, 2, and 3 studies
Austin Kulasekararaj, Diego Vila Cle, Philip Scheinberg, Simon Buatois, Leigh Beveridge, Sammy Chebon, Alexander Röth
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Phase III COMMODORE 1 Trial: 2-Year Efficacy and Safety of Crovalimab▼ in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched from Ravulizumab
Jorg Schubert, Hazzaa Alzahrani, Alejandro Contento Gonzalo, Martin Höglund, Jin Seok Kim, Jens Panse, Melissa J Rose Phillip Scheinberg, Yasutaka Ueda, Eng Soo Yap, Muriel Buri, Nicolo Compagno, Brittany Gentile, Sasha Sreckovic, Austin G Kulasekararaj
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Phase III Randomized COMMODORE 2 Trial: 2-Year Efficacy and Safety of Crovalimab▼ in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Naive to Complement Inhibition
Richard J Kelly, Guangsheng He, Andres Brodsky, Chatree Chai-Adisaksopha, Narcisa Sonia Comia, Anna Gaya, Martin Höglund, Ahlam Naila Kori, Je-Hwan Lee, Naoshi Obara, Antonio Risitano, Alexander Röth, Anita Appius, Leigh Beveridge, Brittany Gentile, Sasha Sreckovic, Zilu Zhang, Bing Han
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Phase III Randomized COMMODORE 1 Trial: 2-Year Safety and Efficacy of Crovalimab▼ in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH) Who Switched From Eculizumab
Mustafa N. Yenerel, Diego Villa Clé, Berangere Devalet, Valentina Giai, Cristina Barrenetxea Lekue, Hsuan-Yu Lin, Zsolt Nagy, Jun-ichi Nishimura, Jens Panse, Agnieszka Piekarska, Phillip Scheinberg, Jorg Schubert, Kazutaka Sunami, Anita Appius, Brittany Gentile, Shino Iwase, Himika Patel, Sasha Sreckovic, Austin G Kulasekararaj
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Duration 60mins Paris, France
Phase III COMMODORE 2 and 1 Trials: Characterization of Breakthrough Hemolysis Events in Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) treated with Crovalimab▼ or Eculizumab
Catherine Flynn, Erfan Nur, Jaroslaw Czyz, Gabriela Roncone Gastal, Marek Hus, Austin Kulasekararaj, Chrysavgi Lalayanni, Phillip Scheinberg, Yasutaka Ueda, Alessandro Maria Vannucchi, María Belén Vidriales, Iige Viigimaa, Simon Buatois, Alice C. Chang, Sammy Chebon, Alexander Röth
Haematology | Paroxysmal Nocturnal Hemoglobinuria

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.